POT1: A Potential Drug Target and Biomarker for Telomere Maintenance

Target Name: POT1

NCBI ID: G25913

POT1

POT1: A Potential Drug Target and Biomarker for Telomere Maintenance

Telomeres are repetitive DNA sequences that protect the ends of chromosomes from degradation, fusion, and other forms of damage. As telomeres age, their shortening contributes to the eventual failure of cellular processes, including DNA replication and transcription. The telomere-proximity gene (TPM) encodes a protein called telomere-proxima (TPM), which is involved in regulating telomere length and dynamics. Telomere-binding proteins (TBP) are known to interact with TPM and help maintain telomere stability. POT1 is a member of the TBP family and has been shown to interact with TPM1, another telomere-proxima protein. In this article, we discuss the potential implications of POT1 as a drug target and biomarker for telomere maintenance.

Pot1: A Putative Drug Target

POT1 is a 21-kDa protein that was identified as a potential drug target in a study by Kim and colleagues (2011). The authors proposed that POT1 could serve as a therapeutic target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders, due to its involvement in the regulation of cellular processes that are disrupted in these conditions.

POT1 functions as a negative regulator of TPM1, which is a known Telomere Proxima (TPM) interacting protein (TBP). TPM1 is a 26-kDa protein that is involved in the regulation of telomere length and dynamics. POT1 interacts with TPM1 and prevents its binding to TPM1-like molecules, which could lead to the accumulation of TPM1-bound molecules and contribute to the dysfunction of TPM1.

POT1 has been shown to play a crucial role in the regulation of cellular processes that are critical for the survival of cancer cells. For instance, POT1 has been shown to inhibit the growth of various cancer cell types, including breast, ovarian, and colorectal cancer (10, 11). This suggests that POT1 may be a promising target for cancer therapies that target cell division and survival.

In addition to its potential therapeutic applications, POT1 is also a potential biomarker for telomere dysfunction. As telomeres shorten, the risk of errors in DNA replication and transcription increases, leading to cellular dysfunction and the potential for age-related diseases. POT1 has been shown to be involved in the regulation of telomere length and dynamics, which could make it an informative biomarker for assessing the health of cellular processes.

Pot1 as a Telomere-Proxima Interaction: Implications for Telomere Maintenance

The interaction between POT1 and TPM1 is of particular interest in the context of telomere maintenance. As telomeres shorten, the stress on the ends of chromosomes can lead to the formation of damage-associated molecular patterns (DAMPs), such as DNA-crosslinked structures. These DAMPs can lead to the formation of an NES (nucleosome-associated stress-induced cross-link) complex, which can disrupt the protective functions of telomeres.

The NES complex is composed of various proteins, including TPM1, which can interact with POT1 and other Telomere-Proxima (TPM) proteins to maintain telomere stability. By interacting with TPM1, POT1 can help prevent the formation of the NES complex and maintain the integrity of telomeres.

In summary, the interaction between POT1 and TPM1 is a key component of telomere maintenance. POT1's ability to regulate TPM1 activity and prevent the formation of the NES complex suggests that it may be a valuable drug target and biomarker for

Protein Name: Protection Of Telomeres 1

Functions: Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini. Is a component of the double-stranded telomeric DNA-binding TRF1 complex which is involved in the regulation of telomere length by cis-inhibition of telomerase. Also acts as a single-stranded telomeric DNA-binding protein and thus may act as a downstream effector of the TRF1 complex and may transduce information about telomere maintenance and/or length to the telomere terminus. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Binds to two or more telomeric single-stranded 5'-TTAGGG-3' repeats (G-strand) and with high specificity to a minimal telomeric single-stranded 5'-TAGGGTTAG-3' sequence. Binds telomeric single-stranded sequences internally or at proximity of a 3'-end. Its activity is TERT dependent but it does not increase TERT activity by itself. In contrast, the ACD-POT1 heterodimer enhances telomere elongation by increasing telomerase processivity

The "POT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets